Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Mar;32(3):162–169. doi: 10.1136/jmg.32.3.162

FRAXE and mental retardation.

J C Mulley 1, S Yu 1, D Z Loesch 1, D A Hay 1, A Donnelly 1, A K Gedeon 1, P Carbonell 1, I López 1, G Glover 1, I Gabarrón 1, et al.
PMCID: PMC1050310  PMID: 7783162

Abstract

Mental impairment and instability of the CCG repeat at FRAXE is described in six kindreds. Cosegregation of FRAXA and FRAXE was found within one of these kindreds. Cytogenetic expression of FRAXE was shown to skip a generation when associated with a reduction in size of the CCG expansion when transmitted through a male; however, in general, transmission occurred through females and a copy number increased from one generation to the next. In these respects the behaviour of FRAXE paralleled that of FRAXA. A relationship between FRAXE and non-specific mental impairment is strongly suggested by the occurrence in these families of more mentally impaired male and female carriers, after removal of index cases, than could reasonably be expected by chance.

Full text

PDF
162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anvret M., Ahlberg G., Grandell U., Hedberg B., Johnson K., Edström L. Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet. 1993 Sep;2(9):1397–1400. doi: 10.1093/hmg/2.9.1397. [DOI] [PubMed] [Google Scholar]
  2. Ashizawa T., Dubel J. R., Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology. 1993 Dec;43(12):2674–2678. doi: 10.1212/wnl.43.12.2674. [DOI] [PubMed] [Google Scholar]
  3. Brook J. D. Retreat of the triplet repeat? Nat Genet. 1993 Apr;3(4):279–281. doi: 10.1038/ng0493-279. [DOI] [PubMed] [Google Scholar]
  4. Crowe S. F., Hay D. A. Neuropsychological dimensions of the fragile X syndrome: support for a non-dominant hemisphere dysfunction hypothesis. Neuropsychologia. 1990;28(1):9–16. doi: 10.1016/0028-3932(90)90082-y. [DOI] [PubMed] [Google Scholar]
  5. Donnelly A., Kozman H., Gedeon A. K., Webb S., Lynch M., Sutherland G. R., Richards R. I., Mulley J. C. A linkage map of microsatellite markers on the human X chromosome. Genomics. 1994 Apr;20(3):363–370. doi: 10.1006/geno.1994.1189. [DOI] [PubMed] [Google Scholar]
  6. Flynn G. A., Hirst M. C., Knight S. J., Macpherson J. N., Barber J. C., Flannery A. V., Davies K. E., Buckle V. J. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. J Med Genet. 1993 Feb;30(2):97–100. doi: 10.1136/jmg.30.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamel B. C., Smits A. P., de Graaff E., Smeets D. F., Schoute F., Eussen B. H., Knight S. J., Davies K. E., Assman-Hulsmans C. F., Oostra B. A. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet. 1994 Nov;55(5):923–931. [PMC free article] [PubMed] [Google Scholar]
  8. Hirst M. C., Barnicoat A., Flynn G., Wang Q., Daker M., Buckle V. J., Davies K. E., Bobrow M. The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE. Hum Mol Genet. 1993 Feb;2(2):197–200. doi: 10.1093/hmg/2.2.197. [DOI] [PubMed] [Google Scholar]
  9. Hori T., Yamauchi M., Seki N., Tsuji S., Kondo I. Heritable unstable DNA sequences and hypermethylation associated with fragile X syndrome in Japanese families. Clin Genet. 1993 Jan;43(1):34–38. doi: 10.1111/j.1399-0004.1993.tb04423.x. [DOI] [PubMed] [Google Scholar]
  10. Jones C. T., McIntosh I., Keston M., Ferguson A., Brock D. J. Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet. 1992 Apr;1(1):11–17. doi: 10.1093/hmg/1.1.11. [DOI] [PubMed] [Google Scholar]
  11. Knight S. J., Flannery A. V., Hirst M. C., Campbell L., Christodoulou Z., Phelps S. R., Pointon J., Middleton-Price H. R., Barnicoat A., Pembrey M. E. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993 Jul 16;74(1):127–134. doi: 10.1016/0092-8674(93)90300-f. [DOI] [PubMed] [Google Scholar]
  12. Knight S. J., Voelckel M. A., Hirst M. C., Flannery A. V., Moncla A., Davies K. E. Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am J Hum Genet. 1994 Jul;55(1):81–86. [PMC free article] [PubMed] [Google Scholar]
  13. Loesch D. Z., Hay D. A., Sutherland G. R., Halliday J., Judge C., Webb G. C. Phenotypic variation in male-transmitted fragile X: genetic inferences. Am J Med Genet. 1987 Jun;27(2):401–417. doi: 10.1002/ajmg.1320270219. [DOI] [PubMed] [Google Scholar]
  14. Loesch D. Z., Huggins R., Hay D. A., Gedeon A. K., Mulley J. C., Sutherland G. R. Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet. 1993 Nov;53(5):1064–1073. [PMC free article] [PubMed] [Google Scholar]
  15. Mulley J. C., Staples A., Donnelly A., Gedeon A. K., Hecht B. K., Nicholson G. A., Haan E. A., Sutherland G. R. Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet. 1993 Jan 23;341(8839):236–237. doi: 10.1016/0140-6736(93)90096-y. [DOI] [PubMed] [Google Scholar]
  16. Mulley J. C., Yu S., Gedeon A. K., Donnelly A., Turner G., Loesch D., Chapman C. J., Gardner R. J., Richards R. I., Sutherland G. R. Experience with direct molecular diagnosis of fragile X. J Med Genet. 1992 Jun;29(6):368–374. doi: 10.1136/jmg.29.6.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Parrish J. E., Oostra B. A., Verkerk A. J., Richards C. S., Reynolds J., Spikes A. S., Shaffer L. G., Nelson D. L. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet. 1994 Nov;8(3):229–235. doi: 10.1038/ng1194-229. [DOI] [PubMed] [Google Scholar]
  18. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  19. Reyniers E., Vits L., De Boulle K., Van Roy B., Van Velzen D., de Graaff E., Verkerk A. J., Jorens H. Z., Darby J. K., Oostra B. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet. 1993 Jun;4(2):143–146. doi: 10.1038/ng0693-143. [DOI] [PubMed] [Google Scholar]
  20. Richards R. I., Holman K., Friend K., Kremer E., Hillen D., Staples A., Brown W. T., Goonewardena P., Tarleton J., Schwartz C. Evidence of founder chromosomes in fragile X syndrome. Nat Genet. 1992 Jul;1(4):257–260. doi: 10.1038/ng0792-257. [DOI] [PubMed] [Google Scholar]
  21. Romain D. R., Chapman C. J. Fragile site Xq27.3 in a family without mental retardation. Clin Genet. 1992 Jan;41(1):33–35. doi: 10.1111/j.1399-0004.1992.tb03625.x. [DOI] [PubMed] [Google Scholar]
  22. Theobald T. M., Hay D. A., Judge C. Individual variation and specific cognitive deficits in the fra(X) syndrome. Am J Med Genet. 1987 Sep;28(1):1–11. doi: 10.1002/ajmg.1320280102. [DOI] [PubMed] [Google Scholar]
  23. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  24. Webb G. C., Rogers J. G., Pitt D. B., Halliday J., Theobald T. Transmission of fragile (X) (q27) site from a male. Lancet. 1981 Nov 28;2(8257):1231–1232. doi: 10.1016/s0140-6736(81)91470-7. [DOI] [PubMed] [Google Scholar]
  25. Willems P. J., Van Roy B., De Boulle K., Vits L., Reyniers E., Beck O., Dumon J. E., Verkerk A., Oostra B. Segregation of the fragile X mutation from an affected male to his normal daughter. Hum Mol Genet. 1992 Oct;1(7):511–515. doi: 10.1093/hmg/1.7.511. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES